Literature DB >> 32459039

Clinical and basic research investigations into the long-term effects of prenatal opioid exposure on brain development.

Taylor Boggess1, W Christopher Risher1.   

Abstract

Coincident with the opioid epidemic in the United States has been a dramatic increase in the number of children born with neonatal abstinence syndrome (NAS), a form of withdrawal resulting from opioid exposure during pregnancy. Many research efforts on NAS have focused on short-term care, including acute symptom treatment and weaning of the infants off their drug dependency prior to authorizing their release. However, investigations into the long-term effects of prenatal opioid exposure (POE) on brain development, from the cellular to the behavioral level, have not been as frequent. Given the importance of the perinatal period for human brain development, opioid-induced disturbances in the formation and function of nascent synaptic networks and glia have the potential to impact brain connectivity and cognition long after the drug supply is cutoff shortly after birth. In this review, we will summarize the current state of NAS research, bringing together findings from human studies and preclinical animal models to highlight what is known about how POE can induce significant, prolonged deficits in brain structure and function. With rates of NAS continuing to rise, particularly in regions that already face substantial socioeconomic challenges, we speculate as to the most promising avenues for future research to alleviate this growing multigenerational threat.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  glia; human; neonatal abstinence syndrome; neurons; preclinical; pregnancy

Mesh:

Substances:

Year:  2020        PMID: 32459039     DOI: 10.1002/jnr.24642

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  One-Year Neurodevelopmental Outcomes After Neonatal Opioid Withdrawal Syndrome: A Prospective Cohort Study.

Authors:  Kristen L Benninger; Celine Richard; Sara Conroy; Julia Newton; H Gerry Taylor; Alaisha Sayed; Lindsay Pietruszewski; Mary Ann Nelin; Nancy Batterson; Nathalie L Maitre
Journal:  Perspect ASHA Spec Interest Groups       Date:  2022-06-27

2.  Analysis of Prenatal Exposure to Opioid Analgesics and Scholastic Skills in Children in Fifth Grade in Norway.

Authors:  Johanne Naper Trønnes; Angela Lupattelli; Eivind Ystrom; Hedvig Nordeng
Journal:  JAMA Netw Open       Date:  2022-07-01

Review 3.  Role of Brain Modulators in Neurodevelopment: Focus on Autism Spectrum Disorder and Associated Comorbidities.

Authors:  Ali K Saad; Amal Akour; Abdulla Mahboob; Salahdein AbuRuz; Bassem Sadek
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-16

4.  Identifying the Neurodevelopmental Differences of Opioid Withdrawal.

Authors:  Nynke J van den Hoogen; Charlie H T Kwok; Tuan Trang
Journal:  Cell Mol Neurobiol       Date:  2021-01-12       Impact factor: 5.046

5.  Co-occurrence of preconception maternal childhood adversity and opioid use during pregnancy: Implications for offspring brain development.

Authors:  Madeleine C Allen; Nora K Moog; Claudia Buss; Elizabeth Yen; Hanna C Gustafsson; Elinor L Sullivan; Alice M Graham
Journal:  Neurotoxicol Teratol       Date:  2021-09-30       Impact factor: 4.071

6.  Alterations in Excitatory and Inhibitory Synaptic Development Within the Mesolimbic Dopamine Pathway in a Mouse Model of Prenatal Drug Exposure.

Authors:  Taylor Boggess; James C Williamson; Ethan B Niebergall; Hannah Sexton; Anna Mazur; Richard D Egleton; Lawrence M Grover; W Christopher Risher
Journal:  Front Pediatr       Date:  2021-12-13       Impact factor: 3.418

7.  Infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use.

Authors:  Madelyn H Labella; Rina D Eiden; Alexandra R Tabachnick; Tabitha Sellers; Mary Dozier
Journal:  Neurotoxicol Teratol       Date:  2021-06-08       Impact factor: 4.071

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.